- $1.53bn
- $2.08bn
- CA$2.01bn
- 52
- 80
- 25
- 51
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 1,747 | 1,141 | 2,041 | 3,415 | 2,008 |
Cost of Revenue | |||||
Gross Profit | 1,086 | 596 | 1,481 | 2,681 | 1,317 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 1,604 | 3,011 | 5.71 | 1,347 | 2,271 |
Operating Profit | 143 | -1,871 | 2,035 | 2,068 | -263 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | 141 | -1,877 | 1,382 | 2,051 | -278 |
Provision for Income Taxes | |||||
Net Income After Taxes | 32.8 | -1,517 | 1,149 | 1,313 | -238 |
Net Income Before Extraordinary Items | |||||
Net Income | 32.8 | -1,517 | 1,149 | 1,313 | -238 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 32.8 | -1,517 | 1,149 | 1,313 | -238 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.402 | -2.68 | 0.313 | 7.07 | 2.24 |
Dividends per Share |